Design and synthesis of metabolically stable atrial natriuretic factor analogs: Amino- and carboxy-terminal stabilization

Add time:09/03/2019    Source:sciencedirect.com

Two analogs of rat atrial natriuretic factor, rANF7–28-NH2 and [Mpr7, Ala2O,D-Arg27]rANF7–27-NH2 were prepared by the solid-phase method. These peptides had 2-fold and 7-fold less affinity, respectively, than rANF1–28 in binding to membranes prepared from cultured aortic smooth muscle cells, and both peptides were 5-fold less potent than rANF1–28 in relaxing serotonin-contracted rabbit aortic rings. rANF7–28-NH2 was rapidly degraded by rat kidney homogenates but [Mpr7Ala2O,D-Arg27]rANF7–27-NH2 had enhanced stability against rat kidney homogenate degradation. However, this in vitro stability did not translate into an extended duration of action in vivo.

We also recommend Trading Suppliers and Manufacturers of atrial, natriuretic factor (1-28), Ala(8)- (cas 114076-99-2). Pls Click Website Link as below: cas 114076-99-2 suppliers

Prev:Radioreceptor assay for atrial natriuretic factor
Next:Technical noteEfficient synthesis of the 18F-labelled 3-O-methyl-6-[18F]fluoro-L-DOPA)